by Madaline Spencer | Apr 24, 2025
A new study published in American Journal of Hematology compared two treatment options for Graft versus host disease (GVHD). Graft Versus Host Disease GVHD is a rare complication that can occur after a stem cell or bone marrow transplant. It is caused by the newly...
by Madaline Spencer | Apr 23, 2025
Sindhu Ramchandren, MD, Executive Medical Director, Neuroscience and Disease Cluster Lead for Neuroimmunology and Neuromuscular Disorders at Johnson & Johnson, discusses updated results from the Vivacity-MG3 clinical trial in patients with generalized myasthenia...
by Madaline Spencer | Apr 22, 2025
A recent study published in Liver International analyzed patients with primary biliary cholangitis (PBC) who presented with higher IgG levels at diagnosis. Primary Biliary Cholangitis PBC is a chronic, progressive liver disease in which the bile ducts become...
by Madaline Spencer | Apr 21, 2025
Michael Weiss, MD, Department of Neurology, University of Washington Medical Center, discusses results from the RAISE clinical trial testing the safety and efficacy of zilucoplan in patients with myasthenia gravis (MG). MG is a chronic autoimmune...
by Madaline Spencer | Apr 18, 2025
Richard Lafayette, MD, Professor of Medicine, Nephrology and Director of the Glomerular Disease Center at Stanford University Medical Center, discusses the recent approval of Vanrafia (atrasentan) for patients with IgA nephropathy (IgAN). IgAN is a rare...
